Frontier science often stalls at the step that turns a promising result into evidence — the clinical study, the watershed restoration, the retraining cohort. The Foundation lets partners fund that step directly, alongside a founder.
Each track funds a defined, evidence-producing piece of work with a named founder or research team, a scope, and a result that can be reported back.
Underwrite the study that moves a health or medtech venture from promising signal to clinical evidence.
Fund restoration, monitoring and water-security work in a defined catchment, with measurement built in from the start.
Back the retraining and placement of people displaced by automation — the other half of the technology story.
We agree the track, the question the work should answer, and what would count as a result.
The commitment is matched to a founder or research team whose work is ready for that step.
Funds are released against a defined scope of work rather than general overhead.
Partners receive a written account of what the work produced — including what did not work.
Investment capital is patient about returns but impatient about proof. A study that would take a venture two years to justify commercially can be the difference between a treatment reaching people and a result sitting unpublished. The Foundation exists to fund that gap, separately from any investment decision.
The Foundation is governed separately from R3i's investment activity. Funding a project through the Foundation is not an investment, carries no financial return, and confers no interest in any company. Partners considering a commitment should seek their own tax and legal advice in their jurisdiction.
Tell us which track interests you and the scale you have in mind, and we will come back with live projects that fit.